N
Natalia Polanco
Researcher at Complutense University of Madrid
Publications - 56
Citations - 1543
Natalia Polanco is an academic researcher from Complutense University of Madrid. The author has contributed to research in topics: Kidney transplantation & Transplantation. The author has an hindex of 15, co-authored 50 publications receiving 1261 citations.
Papers
More filters
Journal ArticleDOI
COVID-19 in solid organ transplant recipients: A single-center case series from Spain.
Mario Fernández-Ruiz,Amado Andrés,Carmelo Loinaz,Juan F. Delgado,Francisco López-Medrano,Rafael San Juan,Esther A. González,Natalia Polanco,María Dolores Folgueira,Antonio Lalueza,Carlos Lumbreras,José María Aguado +11 more
TL;DR: It is suggested that SARS‐CoV‐2 infection has a severe course in SOT recipients, and c‐reactive protein levels at various points were significantly higher among recipients who experienced unfavorable outcome.
Journal ArticleDOI
Spontaneous Remission of Nephrotic Syndrome in Idiopathic Membranous Nephropathy
Natalia Polanco,E. Gutiérrez,Adelardo Covarsí,Francisco Ariza,A Carreño,Ana Vigil,José Baltar,Gema Fernández-Fresnedo,Carmen Martín,Salvador Pons,Dolores Lorenzo,Carmen Bernis,Pilar Arrizabalaga,Gema Fernández-Juárez,Vicente Barrio,Milagros Sierra,Ines Castellanos,Mario Espinosa,Francisco Rivera,Aniana Oliet,Francisco Fernández-Vega,Manuel Praga +21 more
TL;DR: Spontaneous remission is common among patients with nephrotic syndrome resulting from membranous nephropathy and carries a favorable long-term outcome with a low incidence of relapse.
Journal ArticleDOI
Should Asymptomatic Bacteriuria Be Systematically Treated in Kidney Transplant Recipients? Results From a Randomized Controlled Trial.
Julia Origüen,Francisco López-Medrano,Mario Fernández-Ruiz,Natalia Polanco,E. Gutiérrez,Esther González,E. Mérida,Tamara Ruiz-Merlo,Alejandra Morales-Cartagena,M. A. Pérez-Jacoiste Asín,A. García-Reyne,R. San Juan,María Ángeles Orellana,Amado Andrés,José María Aguado +14 more
TL;DR: Systematic screening and treatment of AB beyond the second month after transplantation provided no apparent benefit among KT recipients, and there were no differences in any of the secondary outcomes.
Journal ArticleDOI
Successful Treatment of Membranous Glomerulonephritis with Rituximab in Calcineurin Inhibitor-Dependent Patients
Alfons Segarra,Manuel Praga,Natalia Ramos,Natalia Polanco,Isabel Cargol,Elena Gutierrez-Solis,M. Rosa Gomez,Bruno Montoro,Joaquim Camps +8 more
TL;DR: In patients with MGN with long-term CNI dependence, rituximab can be an effective tool to overcome dependence on CNI, thus avoiding the risk of nephrotoxicity related to the chronic exposure to these drugs.
Journal ArticleDOI
Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C
Inmaculada Fernández,Raquel Muñoz-Gómez,Juan Manuel Pascasio,Carme Baliellas,Natalia Polanco,Nuria Esforzado,Ana Arias,Martín Prieto,Lluis Castells,Valentín Cuervas-Mons,Olga Hernandez,Javier Crespo,Jose Luis Calleja,Xavier Forns,María-Carlota Londoño +14 more
TL;DR: Antiviral therapy with DAAs was highly efficacious and safe in KT recipients and a non-negligible number of patients, most of them cirrhotic, developed mild allograft dysfunction and a significant proportion of patients required immunosuppression dose adjustment, warranting a close follow-up during therapy.